Cargando…
Genetic Approaches for the Treatment of Giant Axonal Neuropathy
Giant axonal neuropathy (GAN) is a pediatric, hereditary, neurodegenerative disorder that affects both the central and peripheral nervous systems. It is caused by mutations in the GAN gene, which codes for the gigaxonin protein. Gigaxonin plays a role in intermediate filament (IF) turnover hence los...
Autores principales: | Shirakaki, Satomi, Roshmi, Rohini Roy, Yokota, Toshifumi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9865904/ https://www.ncbi.nlm.nih.gov/pubmed/36675752 http://dx.doi.org/10.3390/jpm13010091 |
Ejemplares similares
-
Pharmacological Profile of Viltolarsen for the Treatment of Duchenne Muscular Dystrophy: A Japanese Experience
por: Roshmi, Rohini Roy, et al.
Publicado: (2021) -
Giant Axonal Neuropathy: Clinical, Radiological, and Genetic Features
por: Garg, Meenal, et al.
Publicado: (2018) -
Pili canaliculi as manifestation of giant axonal neuropathy
por: de Almeida Jr., Hiram Larangeira, et al.
Publicado: (2016) -
Explaining intermediate filament accumulation in giant axonal neuropathy
por: Opal, Puneet, et al.
Publicado: (2013) -
Expanding the genetic spectrum of giant axonal neuropathy: Two novel variants in Iranian families
por: Ashrafi, Mahmoud Reza, et al.
Publicado: (2023)